Hjem › Myasthenia gravis › Arizona
Myasthenia gravis kliniske forsøg i Arizona
7 studier for Myasthenia gravis søger deltagere på steder i Arizona.
Byer i Arizona
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10104, Scottsdale
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07463521Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Arizona Neuroscience Research, LLC, Phoenix
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT06463587A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- Phoenix Children's Hospital, Phoenix
RekruttererFase 2/3
Alder 2 til 17 · Alle køn · Opdateret 31. jul. 2026 · NCT05265273Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1017, Phoenix
- Site Number - 1025, Scottsdale
- Site Number - 1042, Tucson
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Neuromuscular Research Center and Clinic, Paradise Valley
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- HonorHealth Neurology - Bob Bové Neuroscience Institute, Scottsdale
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. jun. 2026 · NCT06456580Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Scottsdale
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 18. feb. 2026 · NCT04202341Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.